The role of the oncology nurse in optimizing the patient journey in advanced breast cancer
DOI:
https://doi.org/10.31877/on.2024.49.02Keywords:
Advanced breast cancer, Nurse, Patient journey, Multidisciplinary, Health-related quality of lifeAbstract
Breast cancer is the most common cancer in women worldwide and the second most common cancer in Portugal, according to GLOBOCAN 2020. Advanced breast cancer is the leading cause of death and the stage that requires the most care, but several needs remain in the patient journey. A group of nursing experts gathered to identify the main needs of patients with advanced breast cancer throughout their journey, gaps in these needs in Portuguese institutions, and how to address them to optimize the continuum of care and thus health outcomes with quality of life. Four key moments in the patient journey were considered - diagnosis, first line of treatment, monitoring, and advanced lines of treatment and beyond - and, in each, a set of Nursing lines of action were proposed, which the authors believe have the potential to optimize the management of patients with advanced breast cancer in Portugal.
Downloads
References
Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin 2021; 71: 209–49.
International Agency for Research on Cancer WHO. GLOBOCAN 2020 - Portugal Fact Sheet. https://gco.iarc.fr/today/data/factsheets/populations/620-portugal-fact-sheets.pdf. 2021. Available from: https://gco.iarc.fr/today/data/factsheets/populations/620-portugal-fact-sheets.pdf.
Cardoso F, Spence D, Mertz S, et al. Global analysis of advanced/metastatic breast cancer: Decade report (2005–2015). The Breast 2018; 39: 131–8.
Howlader, N; Noone, AM; Krapcho, M; et al. SEER Cancer Statistics Review, 1975-2013, National Cancer Institute. Based on November 2015 SEER Data Submission. Bethesda. Available from: https//seer.cancer.gov/archive/csr/1975_2013/. Accessed July 10, 2020. 2016.
Cardoso F, Paluch-Shimon S, Senkus E, et al. 5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5). Ann Oncol 2020; 31: 1623–49.
Mayer M, Grober SE. Silent Voices: Women with Advanced (Metastatic) Breast Cancer Share Their Needs and Preferences for Information, Support and Practical Resources. White Pap. Living Beyond Breast Cancer. 2006. Available from:https://www.researchgate.net/publication/274510595_Silent_Voices_Women_with_Advanced_Metastatic_Breast_Cancer_Share_Their_Needs_and_Preferences_for_Information_Support_and_Practical_Resources.
Au A, Lam W, Tsang J, et al. Supportive care needs in Hong Kong Chinese women confronting advanced breast cancer. Psychooncology 2013; 22: 1144–51.
Ecclestone C, Chow R, Pulenzas N, et al. Quality of life and symptom burden in patients with metastatic breast cancer. Support Care Cancer 2016; 24: 4035–43.
Kadravello A, Tan S-B, Ho G-F, Kaur R, Yip C-H. Exploring Unmet Needs from an Online Metastatic Breast Cancer Support Group: A Qualitative Study. Medicina (B Aires) 2021; 57: 693.
Reed E, Simmonds P, Haviland J, Corner J. Quality of Life and Experience of Care in Women With Metastatic Breast Cancer: A Cross-Sectional Survey. J Pain Symptom Manage 2012; 43: 747–58.
Uchida M, Akechi T, Okuyama T, et al. Patients’ Supportive Care Needs and Psychological Distress in Advanced Breast Cancer Patients in Japan. Jpn J Clin Oncol 2011; 41: 530–6.
Demicheli R, Biganzoli E, Boracchi P, Greco M, Retsky MW. Recurrence dynamics does not depend on the recurrence site. Breast Cancer Res 2008; 10: R83.
Retsky M, Demicheli R, Hrushesky WJM. Does surgery induce angiogenesis in breast cancer? Indirect evidence from relapse pattern and mammography paradox. Int J Surg 2005; 3: 179–87.
Cardoso F, Kyriakides S, Ohno S, et al. Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2019; 30: 1194–220.
Runowicz CD, Leach CR, Henry NL, et al. American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline. J Clin Oncol 2016; 34: 611–35.
Fallowfield L, Boyle FM, Travado L, et al. Gaps in Care and Support for Patients With Advanced Breast Cancer: A Report From the Advanced Breast Cancer Global Alliance. JCO Glob Oncol 2021; : 976–84.
van Egdom LSE, Oemrawsingh A, Verweij LM, et al. Implementing Patient-Reported Outcome Measures in Clinical Breast Cancer Care: A Systematic Review. Value Heal 2019; 22: 1197–226.
U.S. Food and Drug Administration. Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims - Guidance for Industry. 2009. Available from: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/patient-reported-outcome-measures-use-medical-product-development-support-labeling-claims.
Porter I, Gonçalves-Bradley D, Ricci-Cabello I, et al. Framework and guidance for implementing patient-reported outcomes in clinical practice: evidence, challenges and opportunities. J Comp Eff Res 2016; 5: 507–19.
Ghislain I, Zikos E, Coens C, et al. Health-related quality of life in locally advanced and metastatic breast cancer: methodological and clinical issues in randomised controlled trials. Lancet Oncol 2016; 17: e294–304.
Pe M, Dorme L, Coens C, et al. Statistical analysis of patient-reported outcome data in randomised controlled trials of locally advanced and metastatic breast cancer: a systematic review. Lancet Oncol 2018; 19: e459–69.
REED E, KÖSSLER I, HAWTHORN J. Quality of life assessments in advanced breast cancer: should there be more consistency? Eur J Cancer Care (Engl) 2012; 21: 565–80.
Burguin A, Diorio C, Durocher F. Breast Cancer Treatments: Updates and New Challenges. J Pers Med 2021; 11: 808.
Mierzynska J, Piccinin C, Pe M, et al. Prognostic value of patient-reported outcomes from international
randomised clinical trials on cancer: a systematic review. Lancet Oncol 2019; 20: e685–98.
Jordan K, Aapro M, Kaasa S, et al. European Society for Medical Oncology (ESMO) position paper on supportive and palliative care. Ann Oncol 2018; 29: 36–43.
Modi ND, Danell NO, Perry RNA, et al. Patient-reported outcomes predict survival and adverse events following anticancer treatment initiation in advanced HER2-positive breast cancer. ESMO Open 2022; 7: 100475.
Coelho A, Kendir C, Barrenho E, et al. Patient-Reported Outcomes and Experiences Assessment in Women with Breast Cancer: Portuguese Case Study. Int J Environ Res Public Health 2023; 20: 2931.
Ong WL, Schouwenburg MG, van Bommel ACM, et al. A Standard Set of Value-Based Patient-Centered Outcomes for Breast Cancer. JAMA Oncol 2017; 3: 677.
Bochenek-Cibor J, Górecka M, Storman D, Bała MM. Support for Metastatic Breast Cancer Patients—a Systematic Review. J Cancer Educ 2020; 35: 1061–7.
Breast Cancer Now. The Unsurvivors report. 2019 Available from: https://breastcancernow.org/sites/default/files/bcn_theunsurvivors_campaignreport_oct2019.pdf.
Vila C, Reñones C, Ferro T, et al. Advanced breast cancer clinical nursing curriculum: review and recommendations. Clin Transl Oncol 2017; 19: 251–60.
Eicher M, Kadmon I, Claassen S, et al. Training breast care nurses throughout Europe: The EONS postbasic curriculum for breast cancer nursing. Eur J Cancer 2012; 48: 1257–62.
Vieira C, Almeida D, Almeida M, Almeida SS, Amarelo A, Amorim AP, et al. MAAT (Multidisciplinary Approach in ABC Treatment) – Jornada do Doente com Cancro da Mama Avançado – Consenso Multidisciplinar para Otimizar os Padrões de Cuidados em Portugal. 2023. Available from: https://www.novartis.com/pt-pt/stories/uma-estrategia-multidisciplinar-para-melhorar-vida-das-pessoas-com-cancro-da-mama-metastático
National Comprehensive Cancer Network. NCCN Guidelines, versão 2.2022 - Gestão de angústia. Available from: https://www.nccn.org/professionals/physician_gls/pdf/distress_tool_portuguese.pdf. 2022. https://www.nccn.org/professionals/physician_gls/pdf/distress_tool_portuguese.pdf.
U.S. Department of Health and Human Services, National Institutes of Health NCI. Common Terminology Criteria for Adverse Events (CTCAE) Version 5.0. Available from: https://ctep.cancer.gov/protocoldevelopment/electronic_applications/docs/CTCAE_v5_Quick_Reference_5x7.pdf. 2017.
Brown T, Cruickshank S, Noblet M. Specialist breast care nurses for support of women with breast cancer. Cochrane Database Syst Rev 2021; 2(2):CD005634.
Decoster L, Van Puyvelde K, Mohile S, et al. Screening tools for multidimensional health problems warranting a geriatric assessment in older cancer patients: an update on SIOG recommendations. Ann Oncol 2015; 26: 288–300.
Kenis C, Decoster L, Van Puyvelde K, et al. Performance of Two Geriatric Screening Tools in Older Patients With Cancer. J Clin Oncol 2014; 32: 19–26.
Zhang YH, Xie FY, Chen YW, et al. Evaluating the Nutritional Status of Oncology Patients and Its Association with Quality of Life. Biomed Environ Sci 2018; 31: 637–44.
Harvey C, Palmer J, Hegney D, et al. The evaluation of nurse navigators in chronic and complex care. J Adv Nurs 2019; : jan.14041.
McMullen L. Oncology Nurse Navigators and the Continuum of Cancer Care. Semin Oncol Nurs 2013; 29: 105–17.
Byrne A, Harvey C, Baldwin A. Nurse navigators and person‐centred care; delivered but not valued? Nurs Inq 2021; 28. DOI:10.1111/nin.12402.
Byrne A, Hegney D, Harvey C, et al. Exploring the nurse navigator role: A thematic analysis. J Nurs Manag 2020; 28: 814–21.
Pautasso FF, Zelmanowicz A de M, Flores CD, Caregnato RCA. Atuação do Nurse Navigator: revisão integrativa. Rev Gaúcha Enferm 2018; 39:e20170102.
SNS 24. Testamento Vital. 2023 Available from: https://www.sns24.gov.pt/servico/testamento-vital/.
Campbell KL, WINTERS-STONE KM, WISKEMANN J, et al. Exercise Guidelines for Cancer Survivors: Consensus Statement from International Multidisciplinary Roundtable. Med Sci Sport Exerc 2019; 51: 2375–90.
Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 1983; 67: 361–70.
Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology. JNCI J Natl Cancer Inst 1993; 85: 365–76.
Bjelic-Radisic V, Cardoso F, Cameron D, et al. An international update of the EORTC questionnaire for assessing quality of life in breast cancer patients: EORTC QLQ-BR45. Ann Oncol 2020; 31: 283–8.
Pusic AL, Klassen AF, Scott AM, Klok JA, Cordeiro PG, Cano SJ. Development of a New Patient-Reported Outcome Measure for Breast Surgery: The BREAST-Q. Plast Reconstr Surg 2009; 124: 345–53.
Pusic, Andrea L.; Klassen, Anne; Cano S. BREAST-Q Version 2.0© - A Guide for Researchers and Clinicians. 2017. Available from: https://qportfolio.org/wp-content/uploads/2018/12/BREAST-Q-USERS-GUIDE.pdf.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Joana Cavaco-Silva, Vanessa Leomaro, Anabela Amarelo, Cristina Madeira, Patrícia Rosa, Ana Paula Amorim
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
(CINAHL Ultimate database)
